Extavia

This page shows the latest Extavia news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

to Novartis’ Extavia which had been the only recommended drug after a first cost appraisal.

Latest news

Novartis’ Extavia evades NICE restrictions on MS drugs

Multiple sclerosis patients in England and Wales look set to have just one interferon therapy option after draft NICE guidance backed routine funding for Novartis’ Extavia and rejected other drugs. ... The MS Society said the proposals won’t affect
Biogen Idec sues for patent infringement

Rebif generated global sales of $2.1bn in 2009, and Extavia achieved $20m in the first quarter. ... Novartis received approval last year to sell Extavia and currently pays royalties to Bayer.
FDA approves Extavia for MS

Extavia received EU approval in May 2008 to treat early and relapsing forms of MS. ... Extavia is reportedly the "first in a new planned portfolio" of MS medicines for Novartis.
Novartis gets MS drug approval

Novartis has announced that the European Commission has granted approval for its new multiple sclerosis (MS) treatment, Extavia, and has said it intends to continue broadening its product range in this ... Extavia is the same as the MS treatment Betaferon

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

INDIGENUS and Novartis MS

Indigenus presentation of the launch campaign rolled out for Extavia in Summer 2011.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...